Last updated on February 2018

Human (Autologous) Oral Mucosal Cell Sheet Transplantation After ESD in Patients With Superficial Esophageal Cancer


Brief description of study

The purpose of this study is to evaluate the efficacy and safety of esophageal epithelial regenerative treatment by the transplantation of the product, CLS2702C, to the esophageal wound site after extensive ESD for superficial esophageal cancer.

Detailed Study Description

This study is a multicenter, single-arm, open-label study of CLS2702C/D in patients who plan to undergo ESD for superficial esophageal cancer.

In this study, the efficacy and safety of CLS2702C (cell sheet) transplanted (applied) to the wound site after ESD using CLS2702D (transplantation device) will be evaluated.

Clinical Study Identifier: NCT02866019

Contact Investigators or Research Sites near you

Start Over

Masazumi Kase

National Cancer Center Hospital East
Kashiwa-shi, Japan
  Connect »

Masazumi Kase

National Cancer Center Hospital
Chuo-ku, Japan
  Connect »

Masazumi Kase

Tokyo Women's Medical University Hospital
Shinjuku-ku, Japan
  Connect »